Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
APOPS: Antibiotics in Pediatric Orthopaedic Percutaneous Surgery
NCT03261830Phase 4Completed
- Start
- Aug 2017
- Primary completion
- Mar 2023
- Modality
- Reversible Covalent Inhibitors
- Countries
- 1
01
Overview
Phase 4, randomised, triple-blind trial of cefazolin in post-operative wound infection (SSI) (2 arms). Primary endpoint: Number of Participants With the Presence of Post-Operative Infection at 6 weeks. Started Aug 2017; status: completed.
02
Drugs
cefazolin
03
Conditions
post-operative wound infection (SSI)
Beyond the preview
Go deeper on NCT03261830.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03261830.